Silence Therapeutics (SLN)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

530.00p
   
  • Change Today:
    -22.00p
  • 52 Week High: 649.00
  • 52 Week Low: 339.00
  • Currency: UK Pounds
  • Shares Issued: 89.74m
  • Volume: 69,390
  • Market Cap: £475.60m
  • RiskGrade: 177

SLN Overview

Silence Therapeutics is in the pharma and biotech sector and is currently trading at 530.00p per share. In the last year Silence Therapeutics's share price has ranged from 339.00p to 649.00p and brokers are currently rating this stock as 'strong buy'.
Registrars: Capita Registrars

Key Personnel

Executive Director: Giles Campion
Non-Executive Chairman: Iain Ross
President and CEO: Mark Rothera
Senior Independent Director: Alistair Gray
Non-Executive Dir: Dave Lemus, James Ede-Golightly, Michael H. Davidson, Steven Romano

Contact Details

Address: 22 Melton Street,London,United Kingdom, NW1 2BW
Website: http://www.silence-therapeutics.com/

Listings

Sector: Pharma and Biotech(LSE)
Index: FTSE AIM All-ShareFTSE AIM 50FTSE AIM 100
ISIN: GB00B9GTXM62

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

SLN Market Data

Currency UK Pounds
Share Price 530.00p
Change Today -22.00p
% Change -3.99 %
52 Week High 649.00
52 Week Low 339.00
Volume 69,390
Shares Issued 89.74m
Market Cap £475.60m
RiskGrade 177

SLN Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
43.45% below the market average43.45% below the market average43.45% below the market average43.45% below the market average43.45% below the market average
56% below the sector average56% below the sector average56% below the sector average56% below the sector average56% below the sector average
Price Trend
13.52% above the market average13.52% above the market average13.52% above the market average13.52% above the market average13.52% above the market average
25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average25.81% above the sector average
Income Not Available
Growth
25.58% above the market average25.58% above the market average25.58% above the market average25.58% above the market average25.58% above the market average
22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average22.22% above the sector average

What The Brokers Say

Strong Buy 4
Buy 0
Neutral 1
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for 21-Sep-2021

Time Volume / Share Price
17:08 5,001 @ 530.00p
16:35 3,017 @ 530.00p
16:27 3 @ 520.00p
16:27 197 @ 530.00p
16:27 150 @ 530.00p

Top of Page